ad

3 Credit Rating, Investment Banking and Algorithmic Broking Stocks With a Strong Future Roadmap: CARE Ratings, JM Financial and Share India Securities

CARE Ratings Rs 1,601.60, P/E 25.70. JM Financial Rs 119.69, P/E 10.39. Share India Rs 200.11, P/E 11.17. Closing prices of 14 Oct 2026.


15 Oct 2026 • 9:27 am

3 Credit Rating, Investment Banking and Algorithmic Broking Stocks With a Strong Future Roadmap: CARE Ratings, JM Financial and Share India Securities

Quick Answer

Credit rating, investment banking and algorithmic broking stocks with the clearest long-term roadmaps today include CARE Ratings in credit ratings for bonds, loans and issuers, JM Financial in investment banking, wealth management and lending and Share India in broking and algorithmic trading services. P/E stands at 25.70 for CARE Ratings (industry 33.32), 10.39 for JM Financial (industry 17.72) and 11.17 for Share India (industry 17.72). Demand cycles, input costs and valuation decide how much of that growth the market keeps paying for, so each company's risks need equal attention.

Credit rating, investment banking and algorithmic broking stocks give investors exposure to ratings, deal advisory and trading services for markets and issuers. Issuance activity, trading volumes and fee income decide how much of that demand turns into profit.

This list covers three credit rating, investment banking and algorithmic broking stocks: CARE Ratings for credit ratings for bonds, loans and issuers, JM Financial for investment banking, wealth management and lending and Share India Securities for broking and algorithmic trading services. Every figure comes from the latest reported financials and the 14 October 2026 market close. Companies without complete current figures were left out.

Click Here – Get Free Investment Predictions

Table of Contents

What Are Credit Rating, Investment Banking and Algorithmic Broking Stocks?

Credit rating, investment banking and algorithmic broking stocks are shares of companies that earn fees from markets, ratings, registry work or broking. Results depend on market activity, client additions and fee income, so recurring fee income and margins separate the stronger names.

Credit Rating, Investment Banking and Algorithmic Broking Stocks at a Glance

The table compares size, valuation, return on equity and debt for the three credit rating, investment banking and algorithmic broking stocks as of the 14 Oct 2026 close.

Company CMP (Rs) Market Cap (Rs Cr) P/E Industry P/E ROE Debt to Equity
CARE Ratings 1,601.60 4,631 25.70 33.32 18.36% 0.03
JM Financial 119.69 11,546 10.39 17.72 11.28% 1.09
Share India Securities 200.11 4,073 11.17 17.72 12.28% 0.26

Among capital markets stocks, all three trade at a discount to their industry P/E multiples.

Why Do Credit Rating, Investment Banking and Algorithmic Broking Stocks Have a Strong Roadmap in India?

Credit rating, investment banking and algorithmic broking stocks have a strong roadmap in India because growing bond markets, deal activity and rising trading participation keep adding work for these firms. Three drivers stand out.

  • Rating demand: More issuers and lenders need ratings.
  • Deal flow: Fund raising and advisory work drive fees.
  • Trading activity: Higher participation lifts broking volumes.

CARE Ratings: Rating Fees Anchor the Roadmap

CARE Ratings' roadmap rests on a credit rating agency that rates debt instruments and provides analytical services to borrowers and lenders, with rating fees linked to debt raised by companies supporting earnings.

Revenue grew from Rs 274.82 crore in FY22 to Rs 527.89 crore in FY26, a 92.1% rise, and FY26 revenue was 16.5% higher than FY25. FY26 net profit rose 24.1% to Rs 173.70 crore. Over four years, net profit rose from Rs 76.83 crore in FY22 to Rs 173.70 crore. In Q1 FY27, revenue grew 17.5% to Rs 126.48 crore, and net profit rose 24.5% to Rs 32.99 crore. Operating margin was 53.32% in FY26 and 44.26% in Q1 FY27 against 44.12% a year earlier.

Debt to equity is 0.03 and return on equity is 18.36%. FY26 operating cash flow was Rs 147.57 crore against capital expenditure of Rs 8.30 crore. CARE Ratings paid a dividend of Rs 22 per share for FY26, a yield of 1.43%. At a P/E of 25.70 against an industry P/E of 33.32, the stock trades below its industry multiple.

What to watch: Q1 FY27 operating margin was 44.26% against 53.32% for FY26, so margin stability is the figure to follow as volumes grow.

JM Financial: Investment Banking and Advisory Build the Next Leg

JM Financial's roadmap rests on investment banking, wealth management and asset management, along with a lending book, with capital raising and advisory activity supporting fee income.

Revenue grew from Rs 3,763.28 crore in FY22 to Rs 4,260.59 crore in FY26, a 13.2% rise. FY26 net profit rose 52.4% to Rs 1,176.88 crore. Over four years, net profit rose from Rs 992.37 crore in FY22 to Rs 1,176.88 crore. In Q1 FY27, revenue grew 9.2% to Rs 1,224.66 crore.

Debt to equity is 1.09 and return on equity is 11.28%. JM Financial paid a dividend of Rs 3.25 per share for FY26, a yield of 2.69%. At a P/E of 10.39 against an industry P/E of 17.72, the stock trades below its industry multiple.

What to watch: The P/E of 10.39 against an industry P/E of 17.72 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Share India Securities: Broking and Trading Income Drive the Pipeline

Share India's roadmap rests on broking, proprietary trading and market-linked financial services, with high trading activity supporting broking income.

Revenue grew from Rs 871.01 crore in FY22 to Rs 1,488.85 crore in FY26, a 70.9% rise, and FY26 revenue was 1.3% higher than FY25. FY26 net profit was Rs 323.47 crore. In Q1 FY27, revenue grew 31.0% to Rs 451.55 crore, and net profit rose 47.4% to Rs 124.41 crore.

Debt to equity is 0.26 and return on equity is 12.28%. The dividend yield is 0.51%. At a P/E of 11.17 against an industry P/E of 17.72, the stock trades below its industry multiple.

What to watch: The P/E of 11.17 against an industry P/E of 17.72 leaves valuation less stretched, so the next quarters' growth is the figure to follow.

Best Credit Rating, Investment Banking and Algorithmic Broking Stocks in India: CARE Ratings vs JM Financial vs Share India on Key Financials

Among the best credit rating, investment banking and algorithmic broking stocks in India, CARE Ratings leads on return on equity and the lowest debt to equity; JM Financial leads on the lowest P/E and dividend yield; Share India leads on Q1 FY27 revenue growth. The table puts the numbers side by side.

Metric CARE Ratings JM Financial Share India
FY26 revenue (Rs Cr) 527.89 4,260.59 1,488.85
FY26 net profit (Rs Cr) 173.70 1,176.88 323.47
Q1 FY27 revenue growth (YoY) 17.5% 9.2% 31.0%
Return on equity 18.36% 11.28% 12.28%
P/E ratio 25.70 10.39 11.17
Debt to equity 0.03 1.09 0.26
Dividend yield 1.43% 2.69% 0.51%

Capital market earnings follow market activity, client additions and fee income, so full-year numbers and quarterly trends together give a better view.

How to Evaluate Credit Rating, Investment Banking and Algorithmic Broking Stocks to Buy Before You Invest

A short checklist keeps the research consistent when you screen credit rating, investment banking and algorithmic broking stocks and shortlist credit rating, investment banking and algorithmic broking stocks to buy.

  1. Compare each stock's P/E with its industry P/E, which differs by company here.
  2. Check revenue growth, operating margin and return on equity together.
  3. Check whether revenue growth is turning into profit growth, not only sales.
  4. Read loan growth against funding costs to see how growth is financed.
  5. Watch debt to equity and interest cover before sizing a position.
  6. Spread exposure across companies and business lines instead of one demand cycle.

Check the Univest Screener for live data on these credit rating, investment banking and algorithmic broking stocks

Risks to Consider Before Investing in Credit Rating, Investment Banking and Algorithmic Broking Stocks

  • Market activity: Trading volumes and issue pipelines can shift fee income.
  • Regulation: Rule changes can affect business models.
  • Quarterly trends: A single weak quarter can change near-term earnings, so track results every quarter.

Download the Univest iOS App or Univest Android App to track CARE Ratings, JM Financial and Share India live.

Annual reports and quarterly result presentations are the most reliable places to verify the numbers quoted here, because they show segment details, management commentary and the notes behind each figure.

Final Take: Which Stock Has the Strongest Roadmap?

These three capital markets stocks cover credit ratings, investment banking and algorithmic broking. CARE Ratings leads on return on equity and the lowest debt to equity; JM Financial leads on the lowest P/E and dividend yield; Share India leads on Q1 FY27 revenue growth.

Across credit rating, investment banking and algorithmic broking stocks, each roadmap still has to turn growth into steady profit, so independent research and position sizing matter. Investors should consult a SEBI-registered advisor before acting on any of the credit rating, investment banking and algorithmic broking stocks to buy discussed here.

Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).

FAQs on Credit Rating, Investment Banking and Algorithmic Broking Stocks

Which are the best credit rating, investment banking and algorithmic broking stocks in India with a strong roadmap?

Ans. CARE Ratings, JM Financial and Share India Securities stand out for their roadmaps in credit ratings, investment banking and algorithmic broking. Return on equity ranges from 11.28% to 18.36%.

Is CARE Ratings a good stock to buy now?

Ans. CARE Ratings has a debt to equity ratio of 0.03, a return on equity of 18.36% and a P/E of 25.70 against an industry P/E of 33.32. Valuation, market activity and regulation move results. This article is not investment advice, so consult a SEBI-registered advisor before deciding.

What is the P/E ratio of CARE Ratings, JM Financial and Share India?

Ans. The P/E ratio is 25.70 for CARE Ratings (industry 33.32), 10.39 for JM Financial (industry 17.72) and 11.17 for Share India (industry 17.72). All of them trade below the industry multiple.

Which of these credit rating, investment banking and algorithmic broking stocks has the highest return on equity?

Ans. CARE Ratings has the highest return on equity at 18.36%, followed by Share India Securities at 12.28% and JM Financial at 11.28%.

What are the risks of investing in credit rating, investment banking and algorithmic broking stocks?

Ans. The main risks are market activity, regulation and quarterly trends. Trading volumes and issue pipelines can shift fee income.

How did CARE Ratings, JM Financial and Share India perform in Q1 FY27?

Ans. CARE Ratings reported revenue of Rs 126.48 crore, up 17.5% year on year, and net profit rose 24.5% to Rs 32.99 crore. JM Financial reported revenue of Rs 1,224.66 crore, up 9.2% year on year. Share India Securities reported revenue of Rs 451.55 crore, up 31.0% year on year, and net profit rose 47.4% to Rs 124.41 crore.

Do credit rating, investment banking and algorithmic broking stocks pay dividends?

Ans. Yes, all three companies pay dividends. The dividend yield is 1.43% for CARE Ratings, 2.69% for JM Financial and 0.51% for Share India, based on dividends declared for FY26.

How can I invest in credit rating, investment banking and algorithmic broking stocks in India?

Ans. You can buy credit rating, investment banking and algorithmic broking stocks through a demat and trading account on NSE or BSE after checking each company's financials, margins and valuation. The Univest Screener lets you compare fundamentals before placing an order. Investments in securities are subject to market risk, so consider your risk profile first.

Recent Articles

Note: This blog is for information purpose only. Investments and trading are subject to market risks, read all scheme related documents carefully.

Reviews

user-review-1
user-review-2
user-review-3
user-review-4
user-review-5

RESEARCH ANALYST

Get SEBI Registered
advice on the stocks
trending today.

Get 3 FREE Trade Ideas

+91
for Startups Accelerator 2024

for Startups Accelerator 2024

Trusted by 1Cr Indians

Trusted by 1Cr Indians

Awarded No.1 by Economic Times

Awarded No.1 by Economic Times

GET THE APP

Join 1Cr users today.

SEBI Registered Analyst-backed Picks. Free Demat. One App

  • Free Demat account in under 5 minutes
  • Live market data — Nifty, Sensex, sector insights
  • SEBI Registered analyst-backed stock picks
Get it on Google PlayDownload on the App Store
Stocks:
All|a|b|c|d|e|f|g|h|i|j|k|l|m|n|o|p|q|r|s|t|u|v|w|x|y|z

Copyright 2026 Univest. All rights reserved.
Designed with ❤️ in India

arrow down